Inspire Medical Systems Inc
Company Profile
Business description
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.
Contact
5500 Wayzata Boulevard
Suite 1600
Golden ValleyMN55416
USAT: +1 844 672-4357
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2026
Employees
1,333
Stocks News & Analysis
stocks
Cheap Narrow Moat ASX share continues to face negative sentiment
stocks
ASX energy giant remains cheap following record production
stocks
Strong results from cheap ASX share
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,359.00 | 50.70 | 0.54% |
| CAC 40 | 8,550.93 | 31.72 | 0.37% |
| DAX 40 | 25,149.67 | 163.42 | 0.65% |
| Dow JONES (US) | 49,349.07 | 174.57 | 0.36% |
| FTSE 100 | 10,799.80 | 119.21 | 1.12% |
| HKSE | 26,765.72 | 175.40 | 0.66% |
| NASDAQ | 23,078.27 | 214.59 | 0.94% |
| Nikkei 225 | 58,583.12 | 1,262.03 | 2.20% |
| NZX 50 Index | 13,525.58 | 6.73 | -0.05% |
| S&P 500 | 6,928.27 | 38.20 | 0.55% |
| S&P/ASX 200 | 9,128.30 | 44.20 | 0.49% |
| SSE Composite Index | 4,147.23 | 29.82 | 0.72% |